EFDID: 577620EFD: View Filing

Issuer: Verrica Pharmaceuticals Inc. (0001660334) - D

Accession: 0001231919-25-000594 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001660334
  • Entity Name:
    Verrica Pharmaceuticals Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    44 W. Gay St., Suite 400
    WEST CHESTER, PA 19380
  • Persons:
    Related Persons 10
    Jayson Rieger
    Executive Officer, Director
    John Kirby
    Executive Officer
    David Zawitz
    Executive Officer
    Noah Rosenberg
    Executive Officer
    Paul B. Manning
    Director
    Lawrence Eichenfield
    Director
    Diem Nguyen
    Director
    Mark Prygocki
    Director
    Sean Stalfort
    Director
    Gavin Corcoran
    Director
EDGAR: Offering Information
  • Accession Date:
    12/10/2025
  • First Sale Date:
    11/25/2025
  • Offering Amount:
    $50,017,383
  • Amount Sold:
    $50,017,383
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA, GA, NY, OR, PA, TX, VA
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
TD Securities (USA) LLC 18476 None None OR, TX, GA, NY, CA
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Verrica Pharmaceuticals Inc./s/ Jayson RiegerJayson RiegerChief Executive Officer2025-12-10